5名电离辐射事故患者外周血T细胞T细胞抗原受体、T细胞分化抗原决定簇－3效应的研究

文中报道了５名事故性急性骨髓型放射病患者照后２．５和３．５年外周血Ｔ淋巴细胞Ｔ细胞受体（ＴＣＲ）基因，ＴＣＲ、Ｔ细胞分化抗原决定簇－３（ＣＤ_３）表达与ＴＣＲ／ＣＤ_３复合物功能的辐射效应．发现５名患者于照后２．５年，２名（５．２Ｇｙ和２．４Ｇｙ，５５岁）于照后３．５年外周血Ｔ细胞应答抗ＣＤ３单抗刺激而增殖的能力尚未完全恢复；经同时用ＩＬ－２和抗ＣＤ_３单抗刺激，增殖能力比单用抗ＣＤ_３单抗刺激有所增强；后２名的外周血ＴＣＲ、ＣＤ_３阳性细胞百分率一直低于正常对照和其他患者；并见一患者出现ＤＮＡ重排杂交带型．本文并从ＴＣＲ／ＣＤ_３在介导Ｔ细胞抗原刺激反应中的作用，电离辐射对ＴＣＲ／ＣＤ_３复合物的影响，后果和意义等方面进行了讨论．     

Neuroblastoma-like epidural localization in non-Hodgkin's lymphoma

Summary We report a case of non-Hodgkin's lymphoma with CNS involvement confined to the epidural space causing cranial suture diastasis. Cerebrospinal fluid and bone marrow were normal. Two cases only of cranial epidural lymphoma have been reported in the literature; in both cases, the leptomeninges were also involved but without suture diastasis.     

原发性胃肠道粘膜相关淋巴组织淋巴瘤47例临床病理分析

目的 探讨原发性胃肠道粘膜相关淋巴组织淋巴瘤(GIL-MALT)的临床病理特点。方法 回顾性分析1990～2000年我院经手术及病理证实的47例胃肠道MALT患者临床病理资料。结果 47例患者平均年龄57．2岁，男女比例2．1：1。以腹痛和发热为主。病变分布为胃32例，小肠4例，回盲部及盲肠5例，大肠6例。内窥镜下息内型15例，溃疡型25例，弥漫型7例。除1例为T细胞淋巴瘤，其余均为B细胞淋巴瘤。结论 胃肠道粘膜相关淋巴瘤以中老年为主，男性居多，临床误诊率较高。内窥镜下多次多点活检、深凿活检可提高本病的确诊率。     

原发睾丸恶性淋巴瘤：（附13例报告）

自1977～1988年我院共收治13例原发睾丸恶性淋巴瘤,占同期睾丸恶性肿瘤的11.5％。本病少见,大部分发生在50岁以上。本文50岁以上者10例,约占80％。此病预后差,本文11侧2年内死亡,占85％。5年生存率仅为15％。本文5例术后辅以放、化疗,8例术后单纯化疗,两者生存期无明显差异,故我们认为手术 化疗为本病的首选治疗方案。     

EDOP方案治疗复发难治性恶性淋巴瘤45例分析

目的:观察EDOP方案治疗复发难治性恶性淋巴瘤的疗效和毒副作用。方法:对45例复发难治性恶性淋巴瘤患者采用EDOP联合化疗方案进行治疗。结果:EDOP联合化疗方案有效率为(CR+PR)71.1%,完全缓解率(CR)为33.3%,部分缓解(PR)37.8%。主要不良反应为骨髓抑制和胃肠道反应。结论:EDOP方案治疗难治性或复发性恶性淋巴瘤有效率高,毒副反应低,值得进一步研究和推广。     

PRIMARY LYMPHOMA OF THE PANCREAS

Lymphoma of the pancreas is uncommon. Secondary invasion from contiguous, retroperitoneal lymph node disease is the predominant mode of involvement. Lymphoma originating in and remaining localized to the pancreas is very rare. A case of primary lymphoma confined to the pancreas, in a 35 year old man, is described. Only two other similar cases could be found in the English literature.     

Failure of intensive chemotherapy in poor prognosis non-Hodgkin's lymphoma

In an attempt to improve response and survival rates in patients with non-Hodgkin's lymphoma, a relatively intense six drug regimen MATCOP was developed comprising four-weekly cycles of methotrexate (100mg/m², IV_Y day 8), Adriamycin (30mg/m², IV_Y days 1,2), teniposide (75 mg/rn², IV, day 1), cyclophophamide (300 mg/m², po, days one to five), Oncovin (1.4 mg/m², IV: maximum 2 mg, days 8,15) and prednisolone (100 mg, po, days one to five). A randomised trial was conducted comparing MATCOP with the standard CHOP regimen, comprising three-weekly cycles of cyclophosphamide (750 mg/m², IV, day 1), Adriamycin (50 mg/m², IV, day 1), Oncovin (1.4 mg/m² IV: maximum 2 mg, day 1) and prednisolone (100 mg, PO, days two to six). Eighty patients with large cell lymphoma, diffuse mixed small cleaved and large cell lymphoma or diffuse small cleaved cell lymphoma were randomised, 47 to MATCOP and 33 to CHOP. MATCOP patients experienced increased granulocytopenia, thrombocytopenia (p 0.0001), mucositis (p= 0.002) and infections (p= 0.01) compared to CHOP patients. Complete response rates were similar: 66% for MATCOP patients and 61% for CHOP patients. There were no apparent differences in the time to relapse for patients achieving CR, the time to treatment failure or the overall survival time. Thus despite an increase in toxicity, the more intense regimen MATCOP failed to confer any therapeutic benefit compared with the standard CHOP regimen. Survival was not influenced but toxicity was increased by dose intensification. (Aust NZ J Med 1992; 22: 123–128.)     

Detection of Epstein Barr virus in an hepatic leiomyomatous neoplasm in an adult human immunodeficiency virus 1-infected patient

We report the first case of a human immunodeficiency virus (HIV)-related primary hepatic leiomyoma in an adult patient. The diagnosis was made at autopsy and confirmed by immunohistochemistry. Epstein Barr virus (EBV) was identified in tumour cells by in situ hybridization. Review of the literature revealed 13 cases of visceral myogenic tumours occuring in acquired immunodeficiency syndrome children, and only 2 cases in adults. One was a spinal epidural leiomyoma, the other multiple smooth muscle tumours of the colon and adrenal gland. This is the first report of EBV in smooth muscle neoplastic cells in an HIV-infected adult patient.     

Ga67显像评估纵隔大B细胞淋巴瘤治疗预后的研究

目的:本研究旨在评价纵隔大B细胞淋巴瘤Ga67显像预测疗效的临床价值。方法:39例病人中女24例,男15例,平均年龄(48±5.6)岁,临床病史及组织病理学诊断为纵隔大B细胞淋巴瘤。分别在化疗前、化疗结束后1个月和放疗结束后3个月进行常规的Ga67 SPECT和CT显像,图像分析采用常规的定性方法。结果:Ga67显像结果:在39例病人治疗结束后,有32例病人肿瘤Ga67显像结果为阴性,提示治疗完全有效,随访证实阴性预测率为94%(30/32);7例病人治疗后Ga67显像阳性,表示治疗部分有效或治疗无效。随访证实阳性预测率为86%(6/7),提示Ga67显像阴性的病人预后很好,而治疗后Ga67显像阳性预后很差。CT扫描结果:39例病人进行了治疗前后的胸、腹和盆腔CT扫描,其阴性预测率为83%;而阳性预测率只有25%。结果提示与Ga67显像相比,CT预测疗效的结果难于区分治疗有效、部分有效或无效。结论:Ga67显像在评价纵隔大B细胞淋巴瘤病人治疗反应中明显优于CT扫描。